NCT01026740View on ClinicalTrials.gov

Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Staphylococcal Skin InfectionsStreptococcal Infections
Interventions
DRUG

Ceftobiprole

single intravenous (i.v.) infusion, 500 mg ceftobiprole administered over 2 hours.

Sponsors
All Listed Sponsors
lead

Basilea Pharmaceutica

INDUSTRY